Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Peer Review reports

Original Submission
1 Feb 2005	Submitted	Original manuscript
21 Feb 2005	Reviewed	Reviewer Report - Juan Macías
25 Feb 2005	Reviewed	Reviewer Report - Uberti-Foppa Caterina
2 Mar 2005	Reviewed	Reviewer Report - Ulrich Spengler
8 Mar 2005	Reviewed	Reviewer Report - Bendix Carstensen
Resubmission - Version 2
	Submitted	Manuscript version 2
11 Apr 2005	Author responded	Author comments - Carlo Torti
Resubmission - Version 3
11 Apr 2005	Submitted	Manuscript version 3
20 Apr 2005	Reviewed	Reviewer Report - Ulrich Spengler
25 Apr 2005	Reviewed	Reviewer Report - Juan Macías
26 Apr 2005	Reviewed	Reviewer Report - Uberti-Foppa Caterina
4 May 2005	Reviewed	Reviewer Report - Bendix Carstensen
Resubmission - Version 4
	Submitted	Manuscript version 4
Resubmission - Version 5
	Submitted	Manuscript version 5
6 Jul 2005	Reviewed	Reviewer Report - Bendix Carstensen
14 Jul 2005	Author responded	Author comments - Carlo Torti
Resubmission - Version 6
14 Jul 2005	Submitted	Manuscript version 6
14 Jul 2005	Author responded	Author comments - Carlo Torti
Resubmission - Version 7
14 Jul 2005	Submitted	Manuscript version 7
Publishing
14 Jul 2005	Editorially accepted
14 Jul 2005	Article published	10.1186/1471-2334-5-58

Back to article page